药物化学系

肖友财 副教授(硕士生导师)

来源: 发布时间:2023年09月14日 点击数:

肖友财 副教授

单位:四川大学华西药学院药物化学系

通讯地址:成都市人民南路三段十七号药学科技楼A208

E-mail:xiaoliguo1987@scu.edu.cn


教育及工作经历

2005.09-2009.06 四川大学华西药学院,理学学士

2009.09-2014.06 四川大学华西药学院,药物化学 博士 (导师:陈应春教授)

2014.10-2015.10 瑞典皇家理工学院 (KTH) 博士后 (导师:Cristina Moberg教授)

2015.12-2017.01 美国德雷塞尔大学 博士后 (导师: Joseph. Salvino教授)

2017.02-2018.06 美国 Wistar 研究所 博士后, (导师:Joseph. Salvino教授)

2018.07-至今 四川大学华西药学院,药物化学系,特聘副研究员, 副教授


研究方向

课题组聚焦人工智能辅助的创新药物分子设计与精准治疗药物研发,以药物化学为核心,融合含硼药物化学、肿瘤免疫、靶向偶联药物和放射性核药等交叉研究方向,利用人工智能与计算机辅助药物设计技术,开展新型药物分子的智能发现、结构优化及作用机制研究,发展具有自主知识产权的新型小分子药物及ADC、PDC、RDC等靶向偶联药物,探索药物精准递送与肿瘤免疫调控的协同治疗策略,构建贯穿AI分子设计、化学合成、药理机制、药效评价与转化研究的创新药物研发体系,为重大疾病的精准诊疗提供新型药物与技术,具体研究方向包括:

1.抗体偶联药物(ADC)/核素偶联药物(RDC)研究/新型偶联药物(XDC)研究

2.靶向蛋白降解药物的分子设计及生物机制研究/抗体偶联降解剂(DAC)研究

3.含硼小分子抗耐药菌/抗肿瘤药物化学研究

4.AI多肽药物分子设计

5. 生物酶催化/连续流合成


主讲课程

1. 药物化学,药物化学实验,高等药物化学实验

2.新药研究与开发

3.创新药物研究与评价


科研项目

1.四川省“千人计划”青年人才项目,川特聘第1368,50万,主持,2020.03-2023.03

2.“三苯基膦阳离子载体-抗菌分子偶联物的设计、合成以及抗菌活性研究” 四川省自然科学基金面上项目, 2022NSFSC0619, 20万,主持,2022.01-2023.12

3.“新型六元环硼酸酯骨架化合物的设计、合成及抗耐药菌活性研究”,四川省自然科学基金面上项目, 2025ZNSFSC0686 , 20万,主持,2025.01-2026.12

4.新型抗体偶联药物有效载荷的开发,天府锦城实验室成果转化资助资金项目,2025ZH003号,100万,参与,2025.03-2026.03

5. “超广谱碳青霉烯酶原创小分子抑制剂的研发”,四川省国际港澳台科技创新合作 2022YFH0027,50万元,参与,2022.01–2023.12


近五年发表的代表性论文

1.Ya-LingLi, Mei-Ling He, Jing-Dong Zhang, Ting Shi, Shuang He, Zi-Qiang Chen, Chao-Wen Yang, Xiao-Mei Chen, Shuai Wang,You-Cai Xiao*, Fen-Er Chen*. “Development of pH-resilient boronic acid ENPP1 inhibitor for STING-mediated cancer immunotherapy”,J. Med. Chem.2026,69,24096.(中科院一区)

2.Li-Yan Zhou, Ya-Ling Li, Jing-Dong Zhang, Xin-Yu Zhang, Mei-Ling He, Ting Shi, Zi-Qiang Chen,You-Cai Xiao*, Fen-Er Chen*. “Harnessing unique boron chemistry to develop a new class of non-hydroxamate HDAC inhibitors with validated in vivo efficacy”,J. Med. Chem.2026,69, 6111.(中科院一区)

3.Jing-Dong Zhang, Ya-Ling LI, Dong-Mei Yao, Yue Liu, Kang Cai,You-Cai Xiao*, Fen-Er Chen*. “Highly regio- and enantioselective catalytic 1,6-conjugate addition of Grignard reagents to cyclic dienones”,Org. Lett.2026,28, 5044.(中科院一区)

4.Guo-Qing Liang, Ying-Ying Jiang, Cheng-Long Han, Yao Wang, Si-Yao Wang, Yi-Ting Chen, Gen Li, Guo-Bo Li*,You-Cai Xiao*. “Discovery of 3-methacylic acid substituted benzoxaboroles as dual metallo- and serine-β-lactamase inhibitors”,Eur. J. Med. Chem.2025,293, 117723.(中科院二区)

5.Ya-Ling Li, Jia-Wei Ke, Yue Liu, Dong-Mei Yao, Jing-Dong Zhang,You-Cai Xiao*, Fen-Er Chen*. “Asymmetric conjugated addition of aryl Grignard reagents for the construction of chromanones bearing quaternary stereogenic centers in batch and flow”,Chin. Chem. Lett.2025,36, 110377.(中科院一区)

6.You-Cai Xiao*, Fen-Er Chen. “The vinyl sulfone motif as a structural unit for novel drug design and discovery”,Expert Opin. Drug Discov.2024,19, 239–251 (中科院二区)

7.Clare M Adams,Ramkrishna Mitra,You-Cai Xiao, Peter Michener, Juan Palazzo, Allen Chao , Jitendra Gour, Joel Cassel, Joseph M Salvino*, Christine M Eischen*.“Targeted MDM2 degradation reveals a new vulnerability for p53-inactivated triple-negative breast cancer”,Cancer. Discovery.2023,13, 1210–1229.(中科院一区)

8.Yuan Zhou, Tong Xiong, Li-Yan Zhou, Hong-Yan Li,You-Cai Xiao*, Fen-Er Chen*.“Diastereo- and enantioselective synthesis of borylated 3-hydroxyoxindoles by addition of gem-diborylalkanes to isatins”,Org. Lett.2022,24, 791–796.(中科院一区)

9.Hui-Jing Wang, Yang-Yang Zhong,You-Cai Xiao*, Fen-Er Chen*. “Chemical and chemoenzymatic stereoselective synthesis of β-nucleosides and their analogues”,Org. Chem. Front.2022,9, 1719–1741.(中科院一区)

10.Zhao-Feng Li, Hong-Jiao He, Rong-Hui Wang, Li-Yan Zhou,You-Cai Xiao*, Fen-Er Chen*. “Copper-catalyzed asymmetric alkynylation of pyrazole-4,5-diones using chloramphenicol base-derived hydroxyl oxazoline ligands”,Org. Chem. Front.2022,9, 2792–2796.(中科院一区)

11.You-Cai Xiao*, Jun-Lin Yu, Qing-Qing Dai, Gen Li, and Guo-Bo Li*. “Targeting metalloenzymes by boron-containing metal-binding pharmacophores”,J. Med. Chem.2021,64, 17706–17727.(中科院一区)

12.You-Cai Xiao, Xiao-Pan Chen, Ji Deng, Yu-Hang Yan, Kai-Rong Zhu, Gen Li, Jun-Lin Yu, Jürgen Brem, Fener Chen, Christopher J. Schofield*, Guo-Bo Li*. “Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistance”,Chem. Commun,2021,57, 7709–7712.(中科院二区)

13.Yu-Hang Yan, Zhao-Feng Li, Xiang-Li Ning, Ji Deng, Jun-Lin Yu, Yubin Luo, Zhenling Wang, Guo Li, Guo-Bo Li*,You-Cai Xiao*. “Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases”,Bioorg. Med. Chem. Lett.2021,41, 127956.

14.Marco De Dominici, Patrizia Porazzi, You-Cai Xiao, Allen Chao, Hsin-Yao Tang, Gaurav Kumar, Paolo Fortina, Orietta Spinelli, Alessandro Rambaldi, Luke F Peterson, Svetlana Petruk, Camilla Barletta, Alexander Mazo, Gino Cingolani, Joseph M Salvino*, Bruno Calabretta*, “Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs”,Blood.2020,135, 1560–1573 (中科院一区)

15.Jeremy D. Osko, Nicholas J. Porter, Poli Adi Narayana Reddy, You-Cai Xiao, Johanna Rokka, Manfred Jung, Jacob M. Hooker, Joseph M. Salvino, and David W. Christianson*, “Exploring structural determinants of inhibitor affinity and selectivity in complexes with histone deacetylase 6”,J. Med. Chem.2020,63, 295–308. (中科院一区)